Evidence map›Paper›PMID 36904817›Full record

ArticleSensors (Basel, Switzerland)2023

Validation of a New Scintillating Fiber Dosimeter for Radiation Dose Quality Control in Computed Tomography.

Nicolas Guillochon, Mamoutou Balde, Christian Popotte, Selena Pondard, Corentin Desport, Nicolas Kien, Fanny Carbillet, Ramiro Moreno, Mélodie Munier

Full text read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolas GuillochonFibermetrix, 7 Allée de l'Europe, 67960 Entzheim, France.
Mamoutou BaldeFibermetrix, 7 Allée de l'Europe, 67960 Entzheim, France.
Christian PopotteFibermetrix, 7 Allée de l'Europe, 67960 Entzheim, France.
Selena PondardALARA Expertise, 67960 Entzheim, France.
Corentin DesportALARA Expertise, 67960 Entzheim, France.
Nicolas KienALARA Expertise, 67960 Entzheim, France.
Fanny CarbilletALARA Group, 67960 Entzheim, France.
Ramiro MorenoALARA Expertise, 67960 Entzheim, France.
Mélodie MunierFibermetrix, 7 Allée de l'Europe, 67960 Entzheim, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The IVIscan is a commercially available scintillating fiber detector designed for quality assurance and in vivo dosimetry in computed tomography (CT). In this work, we investigated the performance of the IVIscan scintillator and associated method in a wide range of beam width from three CT manufacturers and compared it to a CT chamber designed for Computed Tomography Dose Index (CTDI) measurements. (2) Methods: We measured weighted CTDI (CTDIw) with each detector in accordance with the requirements of regulatory tests and international recommendations for the minimum, maximum and the most used beam width in clinic and investigated the accuracy of the IVIscan system based on the assessment of the CTDIw deviation from the CT chamber. We also investigated the IVIscan accuracy for the whole range of the CT scans kV. (3) Results: We found excellent agreement between the IVIscan scintillator and the CT chamber for the whole range of beam widths and kV, especially for wide beams used on recent technology of CT scans. (4) Conclusions: These findings highlight that the IVIscan scintillator is a relevant detector for CT radiation dose assessments, and the method associated with calculating the CTDIw saves a significant amount of time and effort when performing tests, especially with regard to new CT technologies.

Indexed as

computed tomographyCTDIdiagnosticdosimetryIVIscanoptical fiberscintillation detectorwide-beam

Identifiers

PMID36904817
PMCPMC10007295

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read34
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.